NCT04163523View on ClinicalTrials.gov

Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

July 21, 2016

Study Completion Date

July 21, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

Zanubrutinib

Trial Locations (5)

2500

Cancer Care Wollongong, Wollongong

3000

Peter Maccallum Cancer Centre, Melbourne

3004

Nucleus Network, Melbourne

3084

Austin Health, Heidelberg

6009

Linear Clinical Research, Nedlands

Sponsors

Lead Sponsor

BeiGene
All Listed Sponsors
lead

BeiGene

INDUSTRY